For anything above 2.5mg per dose, switch to a higher concentration or a larger vial
When to reduce the dose Dose reduction is not failure
5,6,7 The FDA recommends semaglutide for weight loss if patients meet one of the following criteria: Body Mass Index (BMI) 27 kg/m2 (overweight) and have a weight-related comorbidity (e.g., high blood pressure, type 2 diabetes, hypercholesterolemia)
Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation
Purpose-built for physicians GLP-1RAs offer comparable weight loss to bariatric surgery with fewer side effects Key takeaways: Total body weight loss with tirzepatide 15 mg was similar to Roux-en-Y (15.18% vs
A properly reconstituted retatrutide solution should be: Clear (not cloudy or hazy) Colorless to very slightly yellow Free of visible particles or floating material Uniform throughout (no layers or separation) If the solution remains cloudy after 10 minutes of gentle swirling, something may be wrong with the vial
